Received USFDA approval for Famotidine Injection USP, 20 mg/2 mL — a generic equivalent to Merck's Pepcid Injection. Indicated for hospitalized patients with conditions including ulcers, GERD, and Zollinger-Ellison Syndrome. Market size: ~$8.7 million annually (IQVIA MAT March 2026). Will be manufactured at Lupin's Nagpur facility.

Secured a ₹36.50 Cr order from a leading Navratna PSU in the steel sector for supply of bulk industrial commodity — to be executed within ~40 days. Earlier, the company had also won a ₹32.12 Cr order from a Maharashtra-based entity for ash transportation to NHAI road construction sites.

Launched 'The Terraces' — a smart residential project within Estate 361, Sector 36A, Dwarka Expressway. Offers 1.5 & 2-BHK smart homes and duplex loft residences. Phase 1: 120 residences starting ₹2.4 Cr. Project GDV: ₹1,200 Cr. Overall Estate 361 GDV: ₹9,000 Cr across 18.23 acres.

Secured purchase orders worth $238.76 million (~₹2,278.96 Cr) from an international entity — details not disclosed. Additionally received a ₹310 Cr order from Megha Engineering for equipment supply to Kaiga 5 and Kaiga 6 Civil Nuclear Reactors. Combined new orders: ~₹2,588 Cr.

Zydus Worldwide DMCC signed a definitive agreement to acquire all outstanding shares of Assertio Holdings (Nasdaq: ASRT) at $23.50/share — total consideration ~$166.4 million. Assertio's flagship product ROLVEDON is a USFDA-approved long-acting G-CSF biologic for prevention of febrile neutropenia in cancer patients on chemotherapy. Assertio has 170+ community oncology accounts and buy-and-bill infrastructure. Deal structured as a tender offer followed by merger; expected to close in FY2026-27.

Won a major order for a 765kV AIS new substation package in Maharashtra — part of the network expansion scheme to remove transmission constraints in the Pune Region. Involves a new 765/400kV AIS substation at Pune East, plus extensions of 400kV substations at Karjat and Lonikand-II. Order value: ₹200–300 Cr (Major Order category per company framework).

Launched 'Crompton Rhion' — a new super-premium sub-brand designed to showcase advanced technology, innovation, and superior design across multiple product categories. Backed by sustained R&D investments. This separates Crompton's premium positioning from its mainstream range.

Partnered with Divineo Health Care Hospital LLP (Haryana) to offer an Early-Wage-Access (EWA) program to hospital employees — allowing workers to access part of their earned salary during the month. Loan amount is recovered via salary deduction, reducing default risk structurally.

Received tentative USFDA approval for Darolutamide Tablets 300 mg — generic of Bayer's Nubeqa. Darolutamide is an androgen receptor inhibitor for non-metastatic and metastatic castration-resistant/sensitive prostate cancer. Market size: $3,155 million (IQVIA MAT March 2026). Alembic now has 238 cumulative ANDA approvals (219 final + 19 tentative).

Board approved a Joint Venture Agreement between OIL Green Energy (wholly owned subsidiary) and Hindustan Waste Treatment to form a JVC for Compressed Biogas (CBG) project development, implementation, and operation. Approved at board meeting held May 13, 2026.

Successfully commissioned a 14 km MDPE pipeline project in Haryana facilitating PNG connectivity for ~1,000 residential households, converting them from LPG to piped natural gas. Project supports India's City Gas Distribution (CGD) sector push for cleaner domestic fuel.

Board approved additional equity infusion of AUD 1,00,000 into ADF Foods Australia, its wholly owned subsidiary, for working capital support. ADF Foods Australia distributes food products across the Australian market. Investment to be made in one or more tranches.

Secured additional ethanol allocation of 2,923 kiloliters for Q3 of Ethanol Supply Year 2025-26, to be supplied to BPCL and IOCL under EBPP. Estimated order value: ~₹18.71 Cr. To be executed within ESY 2025-26.

Secured a project from the National Mission for Clean Ganga (NMCG), Ministry of Jal Shakti, for aerial LiDAR survey and geotagged videography of the Ganga drainage system across UP, Bihar, Jharkhand, and West Bengal. Uses manned aerial platforms and drones. Outputs include 3D LiDAR point cloud, orthorectified imagery, drainage annotations, and digital decision-support datasets for basin management.

Manufacturing facility at Baddi (Unit I — solid oral dosage forms) cleared the Malta Medicines Authority inspection (Jan 29–Feb 3, 2026) and received EU GMP certification confirming compliance with EC Directive manufacturing standards. Opens the door to regulated European markets.

Haridwar facility approved and included in RDSO Vendor Directory for Constant Contact Side Bearers for freight bogies — under the Developmental Vendor Category with approved manufacturing capacity of 1,12,200 units per annum. This enables Neetu Yoshi to participate in Railway tenders floated by RDSO-approved production units and zonal railways.

Analysts at Antique Stock Broking flagged FY27 as a potential inflection point, driven by a pick-up in Tejas Mk1A deliveries as engine supply constraints ease.

WABAG and PEAK Sustainability Ventures have developed their first Bio-CNG plant at the 70 MLD STP in Dundaheda, Ghaziabad — marking Milestone 1 of their plan to build 100 Bio-CNG plants at STPs across India. Plant captures raw biogas, prevents methane emissions, and upgrades it to renewable Bio-CNG fuel via a BOT model through JV company Ghaziabad Bioenergy.